Skip to content

PHARMEINSA

Active Private limited companyfounded 2022active for 4 yearsAachener Strasse 3, 4780 Saint-VithKBO/BCE: BE 0787.352.463

Lifetime

4 annual accounts with figures on one time axis
peak of €312,562 in 2024
€247,327▼ 20.9%
peak of €184,325 in 2024
€146,188▼ 20.7%
peak of €470,853 in 2024
€5,042▼ 98.9%
€752,132▲ 369%
peak of 1 FTE in 2024
1 FTEunchanged
Board1 name since 2022
1 director
Documentsfilings and deeds
17-03-2026136 days before the deadline
2025financial year
Gross margin from €312,562 to €247,327Dividend €612,000Equity from €470,853 to €5,042Debts from €160,243 to €752,132Cash from €380,267 to €527,185

Key points

from the 2025 annual accounts

Equity

€5,042 from €470,853 in 2024

Equity fell by 99% in 1 year.

Turnover

≈ €1.2m estimated

The accounts state no turnover.

Debts

€752,132 99% of the balance sheet
Suppliers 9%Taxes and wages 22%Other 69%

Liquidity

0.91 was 3.38 in 2024

Short-term debts rose from €160,243 to €752,132.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 109 to 136 days before the end of the period.

Position in the sector

€5,042

Less equity than 87% of companies in retail trade. The sector median is €559,827, over 2,458 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as PHARMEINSA has now. Each dot stands for 6 companies, two years later.

94.0%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for PHARMEINSA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 16-06-2022
  • 100 sharesdeed of 20-06-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0787352463
Incorporation Founding capital of €5,000, 100 shares · Founded by (comparante) · appointed as director · published on 20-06-2022 · Gazette deed
First establishment Aachener Strasse 3, Saint-Vith
All 9 events

Comparable companies

same main activity, similar in size and age
Company
PHARMEINSA Saint-Vith €757,173 €247,327 0.7% 1
Pharmacie de Fétinne Liège €558,769 €197,710 59.1% 1
PHARMA DE COCK Ingelmunster €587,807 €205,824 32.9% 1.1
PIRET PHARMA Charleroi €675,213 €171,047 18.8% 1.1
Het Apotheekhuis Beveren-Kruibeke-Zwijndrecht €720,768 €231,228 32.2% 1.1
Pharmacie Apollo Schaerbeek €628,175 €226,985 33.8% 1.3
APOTHEEK HECHTEL Hechtel-Eksel €808,225 €323,319 76.6% 1.5

These companies have the same main activity as PHARMEINSA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €559,000 and €808,000, founded between 2020 and 2023.

Official details

Source: KBO
Status
Active since 16-06-2022Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.332.501.0954780 Saint-Vith, since 16-06-2022
Financial year end
31 December
Peppol
Reachable since 20-12-2025
Company details

Annual accounts 2025

€757,173▲ 20.0%
Employeeson 31-12-2025
2=
Filing
Filed on 17-03-2026, 136 days before the end of the filing period
Financials

Insights on PHARMEINSA

Solvency fell in 2025 from 74.6% to 0.7% because of the dividend.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMEINSA

What is the company number of PHARMEINSA?
The company number of PHARMEINSA is 0787.352.463. The VAT number is the same number with BE in front: BE 0787.352.463.
Where is PHARMEINSA based?
The registered office is at Aachener Strasse 3, 4780 Saint-Vith.Company details
What does PHARMEINSA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMEINSA?
PHARMEINSA is a private limited company (BV).
When was PHARMEINSA founded?
PHARMEINSA was founded on 16-06-2022.
Is PHARMEINSA still active?
Yes, PHARMEINSA is an active enterprise in the KBO register.
How many employees does PHARMEINSA have?
PHARMEINSA had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMEINSA fall under?
In its 2025 annual accounts, PHARMEINSA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMEINSA?
The turnover in financial year 2025 is about €1.2m. This figure is estimated from the gross margin of €247,327 and 43 comparable companies (NACE 477). It probably lies between €760,000 and €2.4m.
Is PHARMEINSA profitable?
In financial year 2025, PHARMEINSA made a profit of €146,188.
Where can I find the annual accounts of PHARMEINSA?
PHARMEINSA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMEINSA due?
PHARMEINSA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.